Products

Cirrus Resting State fMRI Software
Sora Neuroscience
Neurology AI
Sora Neuroscience's Cirrus Resting State fMRI Software is an FDA-cleared, AI-based tool that rapidly maps brain activity for enhanced precision in neurosurgery and treatment planning for neurological disorders.

See all 1 product →

About Sora Neuroscience

Sora Neuroscience is an emerging healthcare AI company dedicated to advancing patient care through innovative brain mapping software. Their core offering, Cirrus Resting State fMRI Software, is an FDA-cleared solution designed to provide clinically useful and rigorously tested functional MRI analysis tools. This technology, developed and extensively investigated at Washington University in St. Louis, aims to seamlessly integrate into existing clinical workflows, offering a significant advancement in neuroimaging.

For physicians, Cirrus simplifies the acquisition and processing of fMRI data, generating detailed maps of critical brain networks essential for neurosurgical planning. Unlike traditional task-based fMRI, Cirrus utilizes resting-state fMRI, which eliminates the need for patient participation during the scan. This feature broadens its applicability to a wider patient population, including pediatric and cognitively impaired individuals who may struggle with task compliance. The software’s output provides comprehensive brain mapping, not limited to isolated regions, and demonstrates a lower failure rate compared to conventional methods. Its plug-and-play design ensures easy integration with existing surgical navigation platforms, enhancing the precision and efficiency of neurosurgical procedures for conditions such as brain tumors and epilepsy.

Focus Areas

Brain AI software resting-state functional MRI (fMRI) analysis brain mapping neurosurgery planning diagnosis of brain disorders epilepsy brain tumors neurological disorders

Business Intelligence

PartnershipsPrism Clinical Imaging, Washington University in St. Louis (WashU)
TechnologyAI-based brain mapping software, resting-state functional MRI (fMRI) technology, machine learning algorithms, cloud-native, on-premises, plug-and-play integration
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Brain AI Software
Sora Neuroscience specializes in AI-based brain mapping software, with their flagship product being Cirrus Resting State fMRI Software.
Resting-State fMRI Analysis
Their core technology leverages resting-state functional MRI (fMRI) to generate eloquent cortex maps, simplifying fMRI acquisition and analysis without requiring active patient participation.
Brain Mapping
Cirrus creates detailed maps of essential brain networks, crucial for understanding brain function and guiding surgical interventions.
Neurosurgery Planning
The software is designed to assist neurosurgeons in making informed clinical decisions, enhancing the precision of delicate brain surgeries.
Diagnosis of Brain Disorders
In collaboration with platforms like Prism Clinical Imaging, their technology utilizes fMRI and Diffusion Tensor Imaging (DTI) for diagnosing various brain disorders.
Epilepsy Treatment Planning
Sora Neuroscience's tools are specifically applied in planning treatments for conditions such as epilepsy.
Brain Tumor Treatment Planning
Their software aids in planning treatments for brain tumors, helping to balance aggressive resection with functional preservation.
Neurological Disorders
The technology extends to diagnosing and planning treatment for a range of other neurological disorders.
Physician Tip

For physicians, Sora Neuroscience's Cirrus software offers significant advancements in neurosurgical planning and patient care. Its FDA clearance provides a robust validation of its clinical utility. The use of resting-state fMRI is a key differentiator, enabling functional brain mapping without requiring patient participation, which expands accessibility to a broader patient population, including pediatric patients or those unable to perform task-based fMRI. This leads to a higher reliability in generating usable maps for surgical planning (87% success rate compared to approximately two-thirds for task-based fMRI). The software, developed and clinically investigated at Washington University School of Medicine, provides highly accurate and reliable functional MRI maps, aiding neurosurgeons in making critical decisions that balance aggressive tumor resection with the preservation of essential brain functions. Its design for 'plug-and-play' integration into existing imaging and neurosurgery platforms ensures an efficient workflow, allowing for seamless incorporation of detailed brain maps into surgical navigation systems. This comprehensive tool, combining fMRI and DTI, supports precise diagnosis and treatment planning for various brain disorders, including tumors and epilepsy.

Sora Neuroscience's Cirrus software is engineered for 'plug-and-play' integration into existing imaging and neurosurgery platforms. The output brain maps are generated in DICOMu00ae format, allowing them to be easily loaded onto a hospital's surgical navigation platform of choice for seamless display and analysis with current surgical planning systems. Sora Neuroscience also has a non-exclusive distribution agreement with Prism Clinical Imaging, enabling Cirrus to be accessible to users of Prism's brain mapping platform, which provides fMRI, DTI, and other imaging tools with deployment options ranging from on-premises to cloud-based.

Products by Sora Neuroscience

1 product in the directory

Cirrus Resting State fMRI Software
Sora Neuroscience
Neurology AI
Sora Neuroscience's Cirrus Resting State fMRI Software is an FDA-cleared, AI-based tool that rapidly maps brain activity for enhanced precision in neurosurgery and treatment planning for neurological disorders.

Reviews & Opinions

No web reviews on file yet for Sora Neuroscience. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Sora Neuroscience.

Loading videos...

Videos load interactively. If none appear, search YouTube for Sora Neuroscience →

View all on YouTube

Press & Coverage

EIN Presswire
Sora Neuroscience Announces FDA Clearance of Cirrus Resting State fMRI Brain Mapping Software
Sora Neuroscience received FDA clearance for its Cirrus Resting State fMRI Brain Mapping Software, which simplifies the generation of eloquent cortex maps for surgical planning. This AI-based software aims to improve patient care by providing reliable solutions for routine clinical use of resting-state fMRI technology.
2025-06
Yesil Science
Sora Neuroscience's Cirrus Brain Mapping Software Receives FDA Approval
Sora Neuroscience's Cirrus brain mapping software has received FDA clearance, designed to assist neurosurgeons in making informed clinical decisions by utilizing fMRI to create maps of essential brain networks for surgical planning. The company has also partnered with Prism Clinical Imaging for distribution.
2025-06
WashU Medicine
AI-based brain-mapping software receives FDA market authorization - WashU Medicine
Washington University School of Medicine announced that an AI-based brain-mapping software, Cirrus Resting State fMRI Software, developed by their researchers and licensed to Sora Neuroscience, has received FDA authorization. This technology aims to enhance precision in neurosurgeries by rapidly mapping sensitive brain areas.
2025-06
accessdata.fda.gov
510(k) Premarket Notification - K251009
This FDA document details the 510(k) premarket notification for Sora Neuroscience, Inc.'s Cirrus Resting State fMRI Software (K251009), outlining its classification, product code, and intended use as a medical image management and processing system. The clearance was granted on June 6, 2025.
2025-06
Accesswire
Prism Clinical Imaging and Sora Neuroscience Announce Cooperation Agreement
Prism Clinical Imaging and Sora Neuroscience announced a cooperation agreement to assist in the validation testing and commercialization of products for brain resting state functional MRI (rs-fMRI) analysis. Sora Neuroscience is a licensee of technology developed at Washington University in St. Louis.
2024-08
Tracxn
Sora - Funding & Investors
Sora has raised a total of $6.4M over two funding rounds, including a Series A round of $3.9M and a Seed round of $2.5M, with investors such as Peterson Ventures and New Era Capital Partners.
2026-05
PubMed
AI-driven neurosurgery with Sora: applications and complexities
This article discusses the applications and complexities of AI-driven neurosurgery with Sora, highlighting its potential in surgical planning and training, while also addressing limitations and ethical concerns.
2025-01
PubMed
Text-to-video generative artificial intelligence: sora in neurosurgery
This publication explores the potential applications of Sora, an innovation in generative AI, in neurosurgery, including patient education, public health, surgical training, and research dissemination, while also noting current limitations.
2024-06

Frequently Asked Questions

Sora Neuroscience's flagship product is the Cirrus Resting State fMRI Brain Mapping Software, which received FDA clearance in June 2025. This AI-powered software is primarily used for neurosurgery planning, generating eloquent cortex maps from resting-state fMRI data to help surgeons balance aggressive resection with functional preservation.
Cirrus software utilizes AI-based algorithms to analyze resting-state fMRI data, creating detailed maps of critical brain networks such as motor, language, and vision. These maps provide crucial insights for diagnosing and planning treatments for conditions like brain tumors and epilepsy, allowing for more precise surgical interventions.
Sora Neuroscience's Cirrus Resting State fMRI Software is classified as a Class II medical device (Software as a Medical Device - SaMD) and has received FDA clearance (K251009). The company ensures compliance by adhering to the Quality System (QS) regulation (21 CFR Part 820), which includes stringent requirements for design controls and nonconforming product management.
Cirrus offers significant advantages by simplifying fMRI image acquisition and enabling brain mapping for patients unable to perform tasks, such as children or those with cognitive impairments. Its AI-driven analysis provides reliable and accurate mapping of brain networks, improving efficiency and broadening the accessibility of functional MRI for surgical planning.
Sora Neuroscience maintains a crucial partnership with Washington University in St. Louis, which licensed the underlying technology and collaborates on clinical investigations. Additionally, they have a non-exclusive distribution agreement with Prism Clinical Imaging, Inc., integrating Cirrus into Prism's brain mapping platform to enhance workflow and provide a comprehensive suite of imaging tools for clinicians.
Founded in 2020, Sora Neuroscience has raised a total of $1.43 million in funding as of March 2026, indicating early-stage growth and investor confidence. The company emphasizes its commitment to providing clinically useful and rigorously tested tools, with a focus on seamless integration into existing clinical workflows, suggesting a dedication to long-term product support and development.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.